Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

1.

Use of high-sensitivity CRP to predict first cardiovascular events.

Stahl HD.

Lancet. 2007 Apr 14;369(9569):1259-60. No abstract available.

PMID:
17434399
[PubMed - indexed for MEDLINE]
2.

[Statin cuts cardiovascular risk in half].

Einecke D.

MMW Fortschr Med. 2008 Dec 4;150(49-50):12-3. German. No abstract available.

PMID:
19133364
[PubMed - indexed for MEDLINE]
3.

Bringing JUPITER down to earth.

Després JP.

Lancet. 2009 Apr 4;373(9670):1147-8. doi: 10.1016/S0140-6736(09)60448-7. Epub 2009 Mar 28. No abstract available.

PMID:
19329179
[PubMed - indexed for MEDLINE]
4.

JUPITER study highlights value of anti-inflammatory action of rosuvastatin.

[No authors listed]

Cardiovasc J Afr. 2009 May-Jun;20(3):211. No abstract available.

PMID:
19575096
[PubMed - indexed for MEDLINE]
Free Article
5.

The editor's roundtable: the JUPITER trial--initial results and clinical implications.

Ridker PM, Friedewald VE, Davidson MH, Willerson JT, Roberts WC.

Am J Cardiol. 2009 May 15;103(10):1417-25. doi: 10.1016/j.amjcard.2009.02.023. No abstract available.

PMID:
19427439
[PubMed - indexed for MEDLINE]
6.

[Comment from the lipidologic viewpoint].

Riesen WF.

Praxis (Bern 1994). 2009 Feb 4;98(3):125-7. doi: 10.1024/1661-8157.98.3.125. German. No abstract available.

PMID:
19180437
[PubMed - indexed for MEDLINE]
7.

Is hsCRP Back on Board? Implications from the JUPITER Trial.

Koenig W.

Clin Chem. 2009 Feb;55(2):216-8. doi: 10.1373/clinchem.2008.115915. Epub 2008 Dec 12. No abstract available.

PMID:
19074517
[PubMed - indexed for MEDLINE]
Free Article
8.

[Comment from the family practice viewpoint].

Coradi B.

Praxis (Bern 1994). 2009 Feb 4;98(3):131. doi: 10.1024/1661-8157.98.3.131. German. No abstract available.

PMID:
19180439
[PubMed - indexed for MEDLINE]
9.

Rosuvastatin in patients with elevated C-reactive protein.

Jenny-Avital ER.

N Engl J Med. 2009 Mar 5;360(10):1039; author reply 1041-2. No abstract available.

PMID:
19271275
[PubMed - indexed for MEDLINE]
10.

The JUPITER Trial: responding to the critics.

Ridker PM, Glynn RJ.

Am J Cardiol. 2010 Nov 1;106(9):1351-6. doi: 10.1016/j.amjcard.2010.08.025. Epub 2010 Sep 21. No abstract available.

PMID:
21029837
[PubMed - indexed for MEDLINE]
11.

The JUPITER trial: How will it change clinical practice?

Watson KE.

Rev Cardiovasc Med. 2009 Spring;10(2):91-6. Review.

PMID:
19593321
[PubMed - indexed for MEDLINE]
12.

Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?

Couzin J.

Science. 2008 Nov 14;322(5904):1039. doi: 10.1126/science.322.5904.1039. No abstract available.

PMID:
19008423
[PubMed - indexed for MEDLINE]
13.

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Sniderman AD.

Lancet. 2009 Jul 4;374(9683):25; author reply 26-7. doi: 10.1016/S0140-6736(09)61231-9. No abstract available.

PMID:
19577690
[PubMed - indexed for MEDLINE]
14.

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Feeman WE Jr.

Lancet. 2009 Jul 4;374(9683):24; author reply 26-7. doi: 10.1016/S0140-6736(09)61228-9. No abstract available.

PMID:
19577687
[PubMed - indexed for MEDLINE]
15.

Jupiter to Earth: CRP promotes atherothrombosis.

Jialal I, Devaraj S.

Metab Syndr Relat Disord. 2009 Feb;7(1):1-3. doi: 10.1089/met.2009.EDI. No abstract available.

PMID:
19183073
[PubMed - indexed for MEDLINE]
Free PMC Article
16.
17.

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Rosenstein R, Parra D.

Lancet. 2009 Jul 4;374(9683):25; author reply 26-7. doi: 10.1016/S0140-6736(09)61230-7. No abstract available.

PMID:
19577689
[PubMed - indexed for MEDLINE]
18.

[Comment from the cardiologic viewpoint].

Lüscher TF.

Praxis (Bern 1994). 2009 Feb 4;98(3):129-30. doi: 10.1024/1661-8157.98.3.129. German. No abstract available. Erratum in: Praxis (Bern 1994). 2009 Mar 18;98(6):346.

PMID:
19180438
[PubMed - indexed for MEDLINE]
19.

Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

Danchin N.

Lancet. 2009 Jul 4;374(9683):24-5; author reply 26-7. doi: 10.1016/S0140-6736(09)61229-0. No abstract available.

PMID:
19577685
[PubMed - indexed for MEDLINE]
20.

Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.

Fonseca FA, Izar MC.

Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1041-56. doi: 10.1586/erc.09.93.

PMID:
19764857
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk